Jianjiao Lin

606 total citations
20 papers, 228 citations indexed

About

Jianjiao Lin is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jianjiao Lin has authored 20 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Jianjiao Lin's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (4 papers). Jianjiao Lin is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (4 papers). Jianjiao Lin collaborates with scholars based in China. Jianjiao Lin's co-authors include Weimei Tang, Xiaosheng Wu, Jiaying Li, Side Liu, Weiyu Dai, Jide Wang, Xiang Li, Yizhi Xiao, Linjie Hong and Yaying Chen and has published in prestigious journals such as Oncogene, Cancer Letters and Cell Death and Disease.

In The Last Decade

Jianjiao Lin

16 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianjiao Lin China 8 173 96 52 51 31 20 228
Linjie Hong China 7 123 0.7× 74 0.8× 36 0.7× 40 0.8× 27 0.9× 13 168
Yizhi Xiao China 9 202 1.2× 99 1.0× 69 1.3× 45 0.9× 32 1.0× 16 264
Marie K. Kirby United States 5 186 1.1× 110 1.1× 74 1.4× 45 0.9× 28 0.9× 8 257
Xiaojun Man China 9 185 1.1× 115 1.2× 41 0.8× 44 0.9× 14 0.5× 22 244
Melinda Garcia United States 4 166 1.0× 86 0.9× 55 1.1× 94 1.8× 22 0.7× 5 239
Jiansheng Guo China 10 150 0.9× 127 1.3× 57 1.1× 26 0.5× 27 0.9× 19 251
Ouxuan Liu China 11 151 0.9× 91 0.9× 66 1.3× 70 1.4× 30 1.0× 19 246

Countries citing papers authored by Jianjiao Lin

Since Specialization
Citations

This map shows the geographic impact of Jianjiao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjiao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjiao Lin more than expected).

Fields of papers citing papers by Jianjiao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjiao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjiao Lin. The network helps show where Jianjiao Lin may publish in the future.

Co-authorship network of co-authors of Jianjiao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjiao Lin. A scholar is included among the top collaborators of Jianjiao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjiao Lin. Jianjiao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Xiaodong, Tong Tong Wu, Jianjiao Lin, et al.. (2025). SAA3 deficiency exacerbates intestinal fibrosis in DSS-induced IBD mouse model. Cell Death Discovery. 11(1). 25–25.
2.
Yang, Ping, Yidong Chen, Xiaodong Huang, et al.. (2025). Long non-coding RNA-MIR181A1HG acts as an oncogene and contributes to invasion and metastasis in gastric cancer. Oncogene. 44(20). 1517–1529. 3 indexed citations
3.
Zou, Xiaodong, Tao Su, Hui Xiao, et al.. (2025). Disruption of DMD gene leads to altered calcium homeostasis and metabolic shift impacting gastric Cancer cell proliferation and migration. Cancer Cell International. 25(1). 202–202.
5.
Li, Jiaying, Ping Yang, Linjie Hong, et al.. (2024). BST2 promotes gastric cancer metastasis under the regulation of HOXD9 and PABPC1. Molecular Carcinogenesis. 63(4). 663–676. 2 indexed citations
6.
Zhang, Jieming, Zhentao Yu, Ying Peng, et al.. (2024). LINC02139 interacts with and stabilizes XIAP to regulate cell proliferation and apoptosis in gastric cancer. Communications Biology. 7(1). 1497–1497. 2 indexed citations
7.
Dai, Weiyu, Linjie Hong, Luyu Zhang, et al.. (2023). The ATF2/miR-3913-5p/CREB5 axis is involved in the cell proliferation and metastasis of colorectal cancer. Communications Biology. 6(1). 1026–1026. 8 indexed citations
8.
Hong, Linjie, Ping Yang, Luyu Zhang, et al.. (2023). The VAX2-LINC01189-hnRNPF signaling axis regulates cell invasion and migration in gastric cancer. Cell Death Discovery. 9(1). 387–387. 5 indexed citations
9.
Li, Jiaying, Xuehua Liu, Linjie Hong, et al.. (2023). The HOXD9-mediated PAXIP1-AS1 regulates gastric cancer progression through PABPC1/PAK1 modulation. Cell Death and Disease. 14(5). 341–341. 12 indexed citations
10.
Lin, Jianjiao, Tao Su, Qiong Yang, et al.. (2023). Antitumor activity of miR-188-3p in gastric cancer is achieved by targeting CBL expression and inactivating the AKT/mTOR signaling. World Journal of Gastrointestinal Oncology. 15(8). 1384–1399. 1 indexed citations
11.
Dai, Weiyu, Jing Wang, Zhi Wang, et al.. (2021). Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 767644–767644. 27 indexed citations
12.
Dai, Weiyu, Yizhi Xiao, Weimei Tang, et al.. (2021). Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer. Frontiers in Genetics. 12. 661306–661306. 25 indexed citations
13.
Yang, Qiong, Yusi Wang, Mengshu Li, et al.. (2021). HMGA1 promotes gastric cancer growth and metastasis by transactivating SUZ12 and CCDC43 expression. Aging. 13(12). 16043–16061. 21 indexed citations
14.
Wang, Jing, Jing Wang, Xiaosheng Wu, et al.. (2020). The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer. Cancer Letters. 482. 90–101. 45 indexed citations
15.
Liu, Mengwei, Yizhi Xiao, Weimei Tang, et al.. (2020). HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma. Cancer Medicine. 9(11). 3932–3943. 22 indexed citations
16.
Tang, Weimei, Linjie Hong, Weiyu Dai, et al.. (2020). MicroRNA‑500a‑5p inhibits colorectal cancer cell invasion and epithelial‑mesenchymal transition. International Journal of Oncology. 56(6). 1499–1508. 6 indexed citations
17.
Xiao, Yizhi, Weiyu Dai, Weimei Tang, et al.. (2019). The POU2F1/miR-4490/USP22 Axis Regulates Cell Proliferation and Metastasis in Gastric Cancer. SSRN Electronic Journal. 1 indexed citations
18.
Wu, Xiaosheng, Mengwei Liu, Jing Wang, et al.. (2019). Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 277–277. 47 indexed citations
19.
Li, Xiang, Xiaosheng Wu, Jiaying Li, et al.. (2019). HOXD9 Promotes the Growth, Invasion and Metastasis of Gastric Cancer Cells by Transcriptional Activation of RUFY3. SSRN Electronic Journal.
20.
Yan, Qun, et al.. (2019). Human hepatocellular adenoma as a promising cell source for bioartificial liver systems. Experimental and Therapeutic Medicine. 18(2). 1357–1365. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026